🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Ohio › Columbus

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Columbus, OH

9 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Ap rekriteFaz 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06524544

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • ak 11 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Ap rekriteEtid obsèvasyon
  • Ohio State University, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Ap rekriteFaz 3
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Ap rekriteFaz 3
  • The James Cancer Hospital and Solove Research Institute, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06774131

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Ap rekriteFaz 2
  • Ohio State University Hospital, Columbus
  • Ohio State University, Columbus
  • OSU Wexner Medical Center & James Cancer Hospital, Columbus
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Ap rekriteFaz 1/2
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT06943521

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Ap rekriteFaz 2
  • Site 02-017 - Central Ohio Urology Group, Gahanna · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Nov 24, 2025 · NCT03945162

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Columbus
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Columbus

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.